SIGA Technologies SIGA 深 沪
等待开盘 10-07 09:30:00 美东时间
3.27
-0.210
-6.03%
华盛通- 最 高3.675
- 今 开3.48
- 成交量 43.45万股
- 最 低 2.91
- 昨 收 3.48
- 总市值 23.68万
- 52周最高 7.945
- 市盈率 静 3.60
- 换手率 600.05%
- 52周最低 2.83
- 委 比 -66.94%
- 总股本 7.24万
- 历史最高 25.79
- 量 比 0.94
- 振 幅 21.98%
- 历史最低 -0.10
- 每 手 1
- 风险率 1.41%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Why Are Siga Technologies Shares Trading Higher?
SIGA Technologies Inc. (NASDAQ: SIGA) shares are trading higher Friday after the company declared a special cash dividend of $0.60 per share.
03-28 00:40
Earnings Scheduled For November 6, 2025
Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...
2025-11-06 19:12
SIGA Technologies Q4 2024 GAAP EPS $0.63 Down From $1.01 YoY, Sales $81.40M Down From $116.50M YoY
SIGA Technologies (NASDAQ:SIGA) reported quarterly earnings of $0.63 per share. This is a 37.62 percent decrease over earnings of $1.01 per share from the same period last year. The company reported $81.40 million in
2025-03-12 04:07
Earnings Scheduled For March 11, 2025
Companies Reporting Before The Bell • Exagen (NASDAQ:XGN) is projected to repor...
2025-03-11 16:32
Siga Technologies盘中异动 股价大跌5.01%报5.79美元
北京时间2024年12月19日03时55分，Siga Technologies Inc.（SIGA.us）股票出现异动，股价急速下挫5.01%。截至发稿，该股报5.79美元/股，成交量16.7629万股，换手率0.23%，振幅6.81%。 最近的财报数据显示，该股实现营业收入10.01百万美元，净利润1.34百万美元，每股收益0.02美元，毛利8.39百万美元，市盈率4.86倍。 机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。 Siga Technologies Inc.股票所在的制药行业中，整体跌幅为1.40%。其相关个股中，Scilex Holding Company C/...
2024-12-19 03:55
WHO Seeks $135M In Funding To Fight Mpox: Outbreak 'Can Be Controlled, And Can Be Stopped'
The World Health Organization announced a new strategic preparedness and response plan Monday in the fight against mpox, two weeks after declaring a public health emergency on the outbreak. What Happened: The WHO announced a new plan in its fight against the outbreak of mpox. The plan comes as sever...
2024-08-27 03:58
Government Contract Win May Improve Investor Sentiment For SIGA Tech After Disappointing Trial Data: Analyst
On Wednesday, SIGA Technologies, Inc. (NASDAQ:SIGA) announced a new contract with the U.S. Department of Defense (DOD) to procure approximately $9 million of TPOXX. This award is comprised primarily of oral TPOXX, with a small amount of intravenous (IV) TPOXX, and represents the third procurement co...
2024-08-24 02:29
SIGA Technologies Wins $9 Million Antiviral Drug Procurement Contract From Defense Department
04:47 PM EDT, 08/21/2024 (MT Newswires) -- SIGA Technologies (SIGA) said Wednesday it received a roughly $9 million order from the US Department of Defense for its antiviral drug TPOXX, also known as tecovirimat. The order comprises mainly oral TPOXX and a small amount of intravenous TPOXX intended ...
2024-08-22 04:47
SIGA Awarded Contract By U.S. Department Of Defense For The Procurement Of $9M Of TPOXX
SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a commercial-stage pharmaceutical company and leader in infectious diseases, today announced a new contract with the U.S. Department of Defense (DOD) for the procurement of approximately $9 million of TPOXX® (Contract number: W911SR24C0030). This award i...
2024-08-22 04:01
Mpox Variant Sparks Global Concern As Europe, China Ramp Up Screening
Authorities in Europe and China are expediting screening for a deadly new version of mpox that has spread across regions of Africa and has been found in Europe. The European Center for Disease Prevention and Control on Friday raised its risk assessment for mpox and forecasted more imported cases aft...
2024-08-20 02:26
